GenEp Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

  • Investors
  • 1

GenEp Bio General Information

Description

Operator of a biotechnological company intended to create therapies targeting mutations of sodium and other ion channels. The company specializes in selective compounds that modulate sodium channels that result in treatment resistance in certain rare genetic epilepsies, enabling medical professionals to develop effective therapies for these patients' medical needs.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 310 2nd Street SouthEast
  • Suite B
  • Charlottesville, VA 22902
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 310 2nd Street SouthEast
  • Suite B
  • Charlottesville, VA 22902
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenEp Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 26-Apr-2026 Completed Out of Business
4. Early Stage VC (Series 3) 10-Sep-2024 Completed Generating Revenue
3. Seed Round 24-Oct-2021 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out 13-Sep-2021 Completed Generating Revenue
To view GenEp Bio’s complete valuation and funding history, request access »

GenEp Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed-1 195,772 $0.000100 8% $16.09 $16.09 1x $16.09 9.49%
To view GenEp Bio’s complete cap table history, request access »

GenEp Bio Patents

GenEp Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025231324-A1 Imidazole compounds and their use as sodium channel inhibitors Pending 02-May-2024
WO-2025122832-A1 Imidazole compounds and their use as sodium channel inhibitors Inactive 07-Dec-2023
WO-2025122845-A1 Imidazole compounds and their use as sodium channel inhibitors Inactive 07-Dec-2023
AU-2023374468-A1 Imidazole compounds and their use as sodium channel inhibitors Pending 31-Oct-2022
EP-4611747-A1 Imidazole compounds and their use as sodium channel inhibitors Pending 31-Oct-2022 C07D233/64
To view GenEp Bio’s complete patent history, request access »

GenEp Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenEp Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Virginia University
To view GenEp Bio’s complete investors history, request access »

GenEp Bio FAQs

  • When was GenEp Bio founded?

    GenEp Bio was founded in 2021.

  • Where is GenEp Bio headquartered?

    GenEp Bio is headquartered in Charlottesville, VA.

  • What is the size of GenEp Bio?

    GenEp Bio has 2 total employees.

  • What industry is GenEp Bio in?

    GenEp Bio’s primary industry is Biotechnology.

  • Is GenEp Bio a private or public company?

    GenEp Bio is a Private company.

  • What is GenEp Bio’s current revenue?

    The current revenue for GenEp Bio is .

  • How much funding has GenEp Bio raised over time?

    GenEp Bio has raised $8.96M.

  • Who are GenEp Bio’s investors?

    University of Virginia has invested in GenEp Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process